 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - LEXICON PHARMACEUTICALS Inc (LXRX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-18 Purchase | 2019-09-19 4:28 pm | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 50,000 | $3.1 | $155,000 | 227,539 (Direct) | View |
| 2019-09-18 Purchase | 2019-09-19 4:26 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 4,500 | $3.359 | $15,115 | 18,661 (Direct) | View |
| 2019-09-17 Purchase | 2019-09-18 4:39 pm | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 50,000 | $3.128 | $156,403 | 177,539 (Direct) | View |
| 2019-09-13 Purchase | 2019-09-17 5:36 pm | LEXICON PHARMACEUTICALS Inc | LXRX | DEBBANE RAYMOND Director | 103,042 | $2.694 | $277,591 | 4,321,214 (Indirect Direct) | View |
| 2019-09-13 Purchase | 2019-09-17 5:33 pm | LEXICON PHARMACEUTICALS Inc | LXRX | DEBBANE RAYMOND Director | 197,473 | $2.404 | $474,760 | 4,321,214 (Indirect Direct) | View |
| 2019-09-16 Purchase | 2019-09-17 5:27 pm | LEXICON PHARMACEUTICALS Inc | LXRX | SOBECKI CHRISTOPHER J Director | 25,000 | $2.549 | $63,718 | 137,293 (Direct) | View |
| 2019-09-13 Purchase | 2019-09-17 5:23 pm | LEXICON PHARMACEUTICALS Inc | LXRX | SOBECKI CHRISTOPHER J Director | 99,249 | $2.406 | $238,750 | 112,293 (Direct) | View |
| 2019-08-16 Purchase | 2019-08-20 5:02 pm | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 40,000 | $1.351 | $54,029 | 127,539 (Direct) | View |
| 2019-08-02 Purchase | 2019-08-02 4:15 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 10,000 | $1.14 | $11,400 | 43,368 (Direct) | View |
| 2019-08-02 Purchase | 2019-08-02 4:12 pm | LEXICON PHARMACEUTICALS Inc | LXRX | BARKER SAM L Director | 24,000 | $1.175 | $28,200 | 52,187 (Direct) | View |
| 2018-06-27 Purchase | 2018-06-29 4:23 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Minne Pascal Invus L.P. Invus Advisors L.L.C. Invus Public Equities Advisors LLC Director 10% Owner | 182,838 | $12.51 | $2,287,377 | 35,402,688 (Indirect) | View |
| 2018-06-22 Purchase | 2018-06-26 5:32 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Minne Pascal Invus L.P. Invus Advisors L.L.C. Invus Public Equities Advisors LLC Director 10% Owner | 253,725 | $12.99 | $3,295,173 | 35,402,688 (Indirect) | View |
| 2018-06-19 Purchase | 2018-06-21 5:55 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Minne Pascal Invus L.P. Invus Advisors L.L.C. Invus Public Equities Advisors LLC Director 10% Owner | 72,973 | $13.29 | $970,045 | 35,402,688 (Indirect) | View |
| 2018-06-14 Purchase | 2018-06-18 6:56 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Minne Pascal Invus L.P. Invus Advisors L.L.C. Invus Public Equities Advisors LLC Director 10% Owner | 45,784 | $12.98 | $594,399 | 35,402,688 (Indirect) | View |
| 2018-06-08 Purchase | 2018-06-12 6:10 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Minne Pascal Invus L.P. Invus Advisors L.L.C. Invus Public Equities Advisors LLC Director 10% Owner | 235,396 | $12.8 | $3,014,123 | 35,402,688 (Indirect) | View |
| 2018-06-08 Sale | 2018-06-12 4:37 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 10,000 | $12.91 | $129,076 | 35,643 (Direct) | View |
| 2018-06-05 Purchase | 2018-06-07 7:37 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Minne Pascal Invus L.P. Invus Advisors L.L.C. Invus Public Equities Advisors LLC Director 10% Owner | 325,639 | $12.58 | $4,095,065 | 35,402,688 (Indirect) | View |
| 2018-05-25 Purchase | 2018-06-04 5:31 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Minne Pascal Invus L.P. Invus Advisors L.L.C. Invus Public Equities Advisors LLC Director 10% Owner | 416,481 | $12.01 | $5,002,667 | 35,402,688 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-04-26 Option Award | 2019-04-29 5:08 pm | N/A 2029-04-26 | LEXICON PHARMACEUTICALS Inc | LXRX | Palantoni Frank Director | 6,519 | $5.67 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:08 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Palantoni Frank Director | 3,466 | $0 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:07 pm | N/A 2029-04-26 | LEXICON PHARMACEUTICALS Inc | LXRX | Amouyal Philippe Director | 6,519 | $5.67 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:07 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Amouyal Philippe Director | 3,466 | $0 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:06 pm | N/A 2029-04-26 | LEXICON PHARMACEUTICALS Inc | LXRX | NIES ALAN S Director | 6,519 | $5.67 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:06 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | NIES ALAN S Director | 3,466 | $0 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:04 pm | N/A 2029-04-26 | LEXICON PHARMACEUTICALS Inc | LXRX | DEBBANE RAYMOND Director | 6,519 | $5.67 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:04 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | DEBBANE RAYMOND Director | 3,466 | $0 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:03 pm | N/A 2029-04-26 | LEXICON PHARMACEUTICALS Inc | LXRX | Swain Judith L Director | 6,519 | $5.67 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:03 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Swain Judith L Director | 3,466 | $0 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:02 pm | N/A 2029-04-26 | LEXICON PHARMACEUTICALS Inc | LXRX | SOBECKI CHRISTOPHER J Director | 6,519 | $5.67 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:02 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | SOBECKI CHRISTOPHER J Director | 3,466 | $0 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:01 pm | N/A 2029-04-26 | LEXICON PHARMACEUTICALS Inc | LXRX | BARKER SAM L Director | 6,519 | $5.67 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:01 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | BARKER SAM L Director | 3,466 | $0 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:00 pm | N/A 2029-04-26 | LEXICON PHARMACEUTICALS Inc | LXRX | LEFKOWITZ ROBERT J MD Director | 6,519 | $5.67 | 6,519 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-29 5:00 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | LEFKOWITZ ROBERT J MD Director | 3,466 | $0 | 6,519 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 5,807 | $0 | 81,147 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 4,495 | $0 | 81,147 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 2,798 | $0 | 81,147 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 9,555 | $0 | 81,147 (Direct) | View |
| 2019-02-28 Tax Withholding | 2019-03-01 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 8,639 | $5.51 | 81,147 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 5,807 | $0 | 81,147 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 4,495 | $0 | 81,147 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 2,798 | $0 | 81,147 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 9,555 | $0 | 81,147 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:19 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 2,990 | $0 | 19,453 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:19 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 9,727 | $0 | 19,453 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:19 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 2,990 | $0 | 19,453 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:19 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 9,727 | $0 | 19,453 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 2,668 | $0 | 35,869 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 2,075 | $0 | 35,869 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 1,270 | $0 | 35,869 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 4,213 | $0 | 35,869 (Direct) | View |
| 2019-02-28 Tax Withholding | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 2,501 | $5.51 | 35,869 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 2,668 | $0 | 35,869 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 2,075 | $0 | 35,869 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 1,270 | $0 | 35,869 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 4,213 | $0 | 35,869 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 2,352 | $0 | 18,705 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 2,593 | $0 | 18,705 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 8,463 | $0 | 18,705 (Direct) | View |
| 2019-02-28 Tax Withholding | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 4,544 | $5.51 | 18,705 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 2,352 | $0 | 18,705 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 2,593 | $0 | 18,705 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 8,463 | $0 | 18,705 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 5,271 | $0 | 73,952 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 4,085 | $0 | 73,952 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 2,498 | $0 | 73,952 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 8,297 | $0 | 73,952 (Direct) | View |
| 2019-02-28 Tax Withholding | 2019-03-01 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 6,885 | $5.51 | 73,952 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 5,271 | $0 | 73,952 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 4,085 | $0 | 73,952 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 2,498 | $0 | 73,952 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 8,297 | $0 | 73,952 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 4,550 | $0 | 53,907 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 4,227 | $0 | 53,907 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 2,585 | $0 | 53,907 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 8,570 | $0 | 53,907 (Direct) | View |
| 2019-02-28 Tax Withholding | 2019-03-01 5:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 6,809 | $5.51 | 53,907 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 4,550 | $0 | 53,907 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 4,227 | $0 | 53,907 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 2,585 | $0 | 53,907 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 8,570 | $0 | 53,907 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 10,835 | $0 | 106,180 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 8,390 | $0 | 106,180 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 5,363 | $0 | 106,180 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 23,513 | $0 | 106,180 (Direct) | View |
| 2019-02-28 Tax Withholding | 2019-03-01 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 18,641 | $5.51 | 106,180 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 10,835 | $0 | 106,180 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 8,390 | $0 | 106,180 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 5,363 | $0 | 106,180 (Direct) | View |
| 2019-02-28 Exercise | 2019-03-01 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 23,513 | $0 | 106,180 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:15 pm | N/A 2029-02-07 | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 39,770 | $5.16 | 39,770 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 26,510 | $0 | 39,770 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:13 pm | N/A 2029-02-07 | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 148,200 | $5.16 | 148,200 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 79,800 | $0 | 148,200 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:10 pm | N/A 2029-02-07 | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 127,320 | $5.16 | 127,320 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:10 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 68,560 | $0 | 127,320 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:07 pm | N/A 2029-02-07 | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 124,640 | $5.16 | 124,640 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:07 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 67,120 | $0 | 124,640 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:05 pm | N/A 2029-02-07 | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 130,710 | $5.16 | 130,710 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:05 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 70,390 | $0 | 130,710 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:02 pm | N/A 2029-02-07 | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 140,900 | $5.16 | 140,900 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 6:02 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 75,870 | $0 | 140,900 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 5:59 pm | N/A 2029-02-07 | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 442,260 | $5.16 | 442,260 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-08 5:59 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 238,140 | $0 | 442,260 (Direct) | View |
| 2018-06-08 Exercise | 2018-06-12 4:37 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 10,000 | $10.15 | 35,643 (Direct) | View |
| 2018-06-08 Exercise | 2018-06-12 4:37 pm | N/A 2019-02-12 | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 10,000 | $10.15 | 35,643 (Direct) | View |